Goserelin can inhibit ovarian cancer proliferation and simultaneously protect ovarian function from cisplatin: an in vitro and in vivo study

Author： Zhang Ying   Ding Jing Xin   Tao Xiang   Lu Zhi Ying   Wang Jia Jia   Feng Wei Wei   Hua Ke Qin  

Publisher： Maney Publishing

ISSN： 1973-9478

Source： Journal of Chemotherapy, Vol.25, Iss.2, 2013-04, pp. : 96-103

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antitumor properties of salinomycin on cisplatin-resistant human ovarian cancer cells in vitro and in vivo: involvement of p38 MAPK activation

By            

Oncology Reports, Vol. 29, Iss. 4, 2013-01 ,pp. : 1371-1378

Spandidos Publications

Access to resources Recommend Favorite

High level of CFTR expression is associated with tumor aggression and knockdown of CFTR suppresses proliferation of ovarian cancer in vitro and in vivo

By              

Oncology Reports, Vol. 33, Iss. 5, 2015-01 ,pp. : 2227-2234

Spandidos Publications

Access to resources Recommend Favorite

Tumoricidal activity of combining the agonistic DR5 antibody D-6 with cisplatin in C30 cisplatinresistant ovarian cancer in vitro and in vivo

By              

Molecular Medicine Reports, Vol. 10, Iss. 1, 2014-01 ,pp. : 183-190

Spandidos Publications

Access to resources Recommend Favorite

Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study

By De Lena M.   Lorusso V.   Latorre A.   Fanizza G.   Gargano G.   Caporusso L.   Guida M.   Catino A.   Crucitta E.   Sambiasi D.   Mazzei A.  

European Journal of Cancer, Vol. 37, Iss. 3, 2001-02 ,pp. : 364-368

Elsevier

Access to resources Recommend Favorite

TOFA suppresses ovarian cancer cell growth in vitro and in vivo

By                

Molecular Medicine Reports, Vol. 8, Iss. 2, 2013-01 ,pp. : 373-378

Spandidos Publications

Access to resources Recommend Favorite